Atsuo Sasaki, PhD, assistant professor of hematology oncology in the UC College of Medicine Department of Internal Medicine-Division of Hematology Oncology, will give a presentation titled: "The Impact of GTP-Signaling on Cancers and Metabolic Diseases."
The presentation is part of the 2013 UC Department of Cancer Biology's Winter Seminar Series and is open to all interested faculty and staff. It will take place from noon to 1 p.m. Feb. 21 in the Vontz Center for Molecular Studies.
Sasaki joined UC in July 2012 as part of the Brain Tumor Molecular Therapeutics Program, a unique translational research effort aimed at understanding the biological mechanisms of cancerís spread to the brain and developing more effective ways to treat the condition. His laboratory investigates how cells monitor GTP-energy levels and control cellular activity as it related to cancer and metabolic diseases.
Sasaki is part of the UC Brain Tumor Center. The team bridges the University of Cincinnati Neuroscience Institute and University of Cincinnati Cancer Institute, two of four UC College of Medicine and UC Health institutes. Together the UC, UC Health and Cincinnati Children's Hospital Medical Center form the Cincinnati Cancer Center.